Learn More
Medchemexpress LLC N-(2-fluoro-4-((2-(6-methoxy-1,6-dihydropyridin-3-yl)pyrimidin-4-yl)oxy)phenyl)-1,5-dimethyl-3-oxo-2 | 888719-03-7 | 99.5% | 458.42 g·mol⁻¹ | C25H16F2N4O3 | 10 MG

Supplier: Medchemexpress LLC HY1830910MG
MET kinase-IN-4 is a potent, orally active inhibitor of the MET receptor tyrosine kinase intended for research use. It exhibits low-nanomolar MET inhibition and activity against FLT3 and VEGFR-2, supplied as a solid for in vitro and in vivo studies.
- Potent MET inhibition (IC50 1.9 nM).
- Additional activity against FLT3 (IC50 4 nM) and VEGFR-2 (IC50 27 nM).
- High purity: 99.5%.
- Solid, off-white to light yellow appearance.
- Soluble in DMSO at 100 mg/mL; ultrasonic recommended.
- Storage: 4°C sealed; in solution -80°C for 6 months, -20°C for 1 month.
- Molecular formula C25H16F2N4O3; molecular weight 458.42 g·mol⁻¹.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.